Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases Reply

Shapiro Charles L.; Moriarty James P.; Borah Bijan

首页> 外文期刊>Journal of Clinical Oncology >Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases Reply

【24h】

Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases Reply

机译：反应每月一次每月一次，唑妥酸每3个月一次，每月一次乳腺癌和骨骼转移的妇女每月一次恢复

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Journal of Clinical Oncology》 |2018年第10期|共3页
作者
Shapiro Charles L.; Moriarty James P.; Borah Bijan;
展开▼
作者单位

Icahn Sch Med Mt Sinai New York NY 10029 USA;

Mayo Clin Rochester MN USA;

Mayo Clin Rochester MN USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases Reply [J] . Shapiro Charles L., Moriarty James P., Borah Bijan Journal of Clinical Oncology . 2018,第10期

机译：反应每月一次每月一次，唑妥酸每3个月一次，每月一次乳腺癌和骨骼转移的妇女每月一次恢复
2. Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases [J] . Kennedy Lisa, Bhatta Sumita, Hechmati Guy, Journal of Clinical Oncology . 2018,第10期

机译：对每月一次每月一次，唑妥酸每月一次每月一次的成本效果分析，以及每月一次乳腺癌和骨骼转移的妇女的二核。
3. Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) [J] . Shapiro Charles L., Moriarty James P., Dusetzina Stacie, Journal of Clinical Oncology . 2017,第35期

机译：每月唑醇，唑醇酸每3个月的成本效益分析，以及乳腺癌和骨骼转移的妇女每月Denosumab：Calgb 70604（联盟）
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Effect of Zoledronic Acid on Transcriptome of Cell Lines Representing Triple Negative Compared with Luminal Breast Cancer [D] . Abraham, Nissi Mygodis 2018

机译：唑来膦酸对发光性乳腺癌三联阴性细胞系转录组的影响
6. Cost-Effectiveness Analysis of Monthly Zoledronic Acid Zoledronic Acid Every 3 Months and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) [O] . Charles L. Shapiro, James P. Moriarty, Stacie Dusetzina, -1

机译：乳腺癌和骨转移癌女性每月唑来膦酸唑来膦酸每3个月和每月Denosumab的成本-效果分析：CALGB 70604（联盟）
7. Cost-Effectiveness Analysis of Monthly Zoledronic Acid, Zoledronic Acid Every 3 Months, and Monthly Denosumab in Women With Breast Cancer and Skeletal Metastases: CALGB 70604 (Alliance) [O] . Charles L. Shapiro, James P. Moriarty, Stacie Dusetzina, 2017

机译：每月唑醇，唑醇酸每3个月的成本效益分析，以及乳腺癌和骨骼转移的妇女每月Denosumab：Calgb 70604（联盟）

Response to Cost-Effectiveness Analysis of Zoledronic Acid Once Per Month, Zoledronic Acid Once Every 3 Months, and Denosumab Once Per Month in Women With Breast Cancer and Skeletal Metastases Reply

著录项

相似文献

相关主题

期刊订阅